STN: BL 125265
Proper Name: Rotavirus Vaccine, Live, Oral
Tradename: ROTARIX
Manufacturer: GlaxoSmithKline Biologicals
Indication:
- For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9), for use in infants 6 weeks to 24 weeks of age.
Product Information
Supporting Documents
Related Information
You just read:
ROTARIX
News Provided By
June 11, 2022, 23:01 GMT
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today's world. Please see our
Editorial Guidelines
for more information.
